(Q64938910)

English

Cost-effectiveness of immune checkpoint inhibitors in NSCLC according to PD-L1 expression.

scientific article published on 3 November 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

0 references

Cost-effectiveness of immune checkpoint inhibitors in NSCLC according to PD-L1 expression. (English)

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

author name string

Pedro Aguiar

1

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

Luke A Perry

2

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

Gilberto L Lopes

3

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

publication date

3 November 2016

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

Lung cancer management

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

5

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

3

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

119-122

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

Association of insurance with cancer care utilization and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular pathways: next-generation immunotherapy--inhibiting programmed death-ligand 1 and programmed death-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab for the treatment of non-small-cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of PD-L1 expression as a predictive biomarker in advanced non-small-cell lung cancer: a network meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/30643555

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2217/LMT-2016-0016

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

1 July 2019

http://europepmc.org/abstract/PMC/6322585

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q64938910&oldid=1515678010"